Episode
Episode 141: Myeloma Series, Pt.2 - Intro to MGUS and Smoldering Myeloma (2025)
- Published
- Dec 10, 2025
- Processing state
not_requested- Canonical source
- https://www.thefellowoncall.com/tfocpodcast/mgusssmintro2025
Actions
POST https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-141-myeloma-series-pt-2-intro-to-mgus-and-smoldering-myeloma-2025/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-141-myeloma-series-pt-2-intro-to-mgus-and-smoldering-myeloma-2025.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In today’s episode, we continue our myeloma series, this time we’ll delve deeper into the spectrum of plasma cell dyscrasias, including defining MGUS, discussing surveillance of MGUS, defining smoldering myeloma (SM). We are slowly inching our discussion towards the diagnosis of Multiple myeloma (MM)! Content: - Defining MGUS - Discussing risk of progression of MGUS to MM - How to interpret free light chains in renal failure - How do we monitor MGUS patients? - When do we do additional testing in MGUS? - What is smoldering myeloma? - What are myeloma defining events? - How do we risk stratify SM patients? - How do we monitor SM patients? Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co ** Want to review the show notes for this episode and others? Check out our website: Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Youtube